Read More

Immunovant: Q1 Earnings Insights

Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.

IMVT